The etiology of inflammatory bowel disease (IBD) is unknown, but it is thought to arise from
an aberrant immune response to a change in colonic environment in a genetically …

Inflammatory bowel disease (IBD) is a complex set of diseases that lead to chronic
inflammation in the gastrointestinal tract. Although the etiology of IBD is not fully understood …

Fecal microbiota transplantation (FMT), which is thought to have the potential to correct
dysbiosis of gut microbiota, has been used to treat inflammatory bowel disease (IBD) for …

Approximately one-third of patients with Crohn's disease do not respond to conventional
treatments, and some experience significant adverse effects, such as serious infections and …

Human campylobacteriosis constitutes a zoonotic food-borne disease and a progressively
rising health burden of significant socioeconomic impact. We have recently shown that …

Fecal microbiota transplantation (FMT) has been used successfully to treat a variety of
gastroenterological diseases. The alterations of microbiota in mouse models of necrotizing …

Fecal microbiota transplantation (FMT) can inhibit the progression of ulcerative colitis (UC).
However, how FMT modulates the gut microbiota and which biomarker is valuable for …

Background Disturbances in the intestinal microbial community (ie dysbiosis) or presence of
the microbes with deleterious effects on colonic mucosa has been linked to the …

The mammalian colon is home to a microbial ecosystem that enhances resistance to
infection, stimulates mucosal immune defenses, synthesizes essential vitamins, and …

Background & Aims Gut dysbiosis is closely involved in the pathogenesis of inflammatory
bowel disease (IBD). However, it remains unclear whether IBD-associated gut dysbiosis …